Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab.
Lara S van der SchootSelma AtalayMarisol E OteroWietske KievitJuul M P A van den ReekElke M G J de JongPublished in: The British journal of dermatology (2022)